Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Inflammation01:38

Inflammation

Overview
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and validation of a lectin-based assay for detection of IgG Fc glycosylation as a biomarker in lupus nephritis.

Lupus science & medicine·2026
Same author

IgG Glycosylation-Dependent CLEC7A Signaling Drives Podocyte Dysfunction in Lupus Nephritis.

Arthritis & rheumatology (Hoboken, N.J.)·2026
Same author

Beyond barrier function: keratinocytes as orchestrators of humoral immunity.

Immunity & inflammation·2026
Same author

Cell-Targeted Inhibition of CaMK4 Suppresses Tertiary Lymphoid-like Structure Development in Lupus-Prone Mice.

International journal of molecular sciences·2026
Same author

Fat bursts T cells to drive joint inflammation.

Cell metabolism·2026
Same author

Extracellular heme:DNA complexes promote oxidative stress and inflammation during lupus-associated hemolysis.

Proceedings of the National Academy of Sciences of the United States of America·2026

Related Experiment Video

Updated: Jul 3, 2026

Murine Model of Intestinal Ischemia-reperfusion Injury
07:07

Murine Model of Intestinal Ischemia-reperfusion Injury

Published on: May 11, 2016

Complement component C5a mediates hemorrhage-induced intestinal damage.

Sherry D Fleming1, Lauren M Phillips, John D Lambris

  • 1Division of Biology, Kansas State University, Manhattan, Kansas 66506, USA. sdflemin@ksu.edu

The Journal of Surgical Research
|July 22, 2008
PubMed
Summary
This summary is machine-generated.

Complement activation contributes to intestinal damage after hemorrhage. Inhibiting complement component 5a (C5a) protects against this injury, suggesting C5a as a therapeutic target for hemorrhage-associated inflammation.

More Related Videos

Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy
07:05

Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy

Published on: September 27, 2024

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
16:31

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

Related Experiment Videos

Last Updated: Jul 3, 2026

Murine Model of Intestinal Ischemia-reperfusion Injury
07:07

Murine Model of Intestinal Ischemia-reperfusion Injury

Published on: May 11, 2016

Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy
07:05

Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy

Published on: September 27, 2024

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock
16:31

Fixed Volume or Fixed Pressure: A Murine Model of Hemorrhagic Shock

Published on: June 6, 2011

Area of Science:

  • Immunology
  • Gastroenterology
  • Trauma Research

Background:

  • Complement system activation is implicated in intestinal damage and inflammation during hemorrhage.
  • The precise mechanisms linking complement to hemorrhage-induced injury remain unclear, though complement inhibition affects hemodynamic changes.

Purpose of the Study:

  • To investigate the role of complement component 5 (C5) and its effector molecule C5a in the pathogenesis of intestinal injury following hemorrhage.
  • To evaluate the therapeutic potential of targeting the C5a pathway in a mouse model of hemorrhagic shock.

Main Methods:

  • Utilized C57Bl/6 wildtype, complement 5 deficient (C5-/-), and complement 5 sufficient (C5+/+) mice subjected to 25% blood loss.
  • Administered a C5a receptor antagonist (C5aRa) to C57Bl/6 mice post-hemorrhage.
  • Assessed intestinal injury scores, leukotriene B4, and myeloperoxidase production in all experimental groups.

Main Results:

  • Hemorrhage induced significant intestinal inflammation and tissue damage within 2 hours in wildtype mice.
  • C5 deficient mice exhibited significantly reduced intestinal tissue damage (injury score 0.36) compared to wildtype mice (injury score 2.89) after hemorrhage (P < 0.05).
  • Treatment with C5aRa markedly reduced intestinal injury (injury score 0.88), leukotriene B4, and myeloperoxidase levels in hemorrhaged mice compared to untreated controls (P < 0.05).

Conclusions:

  • Complement activation, specifically involving C5 and C5a, plays a critical role in the development of hemorrhage-induced intestinal tissue inflammation and damage.
  • Targeting the C5a pathway with antagonists offers a promising therapeutic strategy for mitigating injury associated with hemorrhagic shock.